Metraipolis › archive › dc_0f31823593ea

Impact of Residual Mediastinal Nodal Disease After Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer — Europe PMC PMID:42738391

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42738391
DOI: 10.3390/cancers18172871
License (as archived): solo-consultazione
Archived: 2026-10-16T03:07:10.885Z
SHA-256 of the archived text: 7da85bc5b063470f2e1e8229b1d0d7b378453b4cd5d4d8c95abab51a2e6d3e2b
Stable URL of this page: https://metraipolis.com/documento/dc_0f31823593ea

How to cite

Impact of Residual Mediastinal Nodal Disease After Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer — Europe PMC PMID:42738391 — Europe PMC (en), https://europepmc.org/article/MED/42738391 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0f31823593ea (Metraipolis archive dc_0f31823593ea, sha256 7da85bc5b063470f2e1e8229b1d0d7b378453b4cd5d4d8c95abab51a2e6d3e2b)

BibTeX

@misc{dc0f31823593ea,
  title = {Impact of Residual Mediastinal Nodal Disease After Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer — Europe PMC PMID:42738391},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42738391},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0f31823593ea; sha256 7da85bc5b063470f2e1e8229b1d0d7b378453b4cd5d4d8c95abab51a2e6d3e2b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42738391. Agents can read the archived copy with the MCP tool read_document.